Nuron Biotech announces acquisition of Wyeth's HibTITER vaccine assets

Links shared publicly online about this topic.

383
total visits

Nuron Biotech announces acquisition of Wyeth's HibTITER vaccine assets

Nuron Biotech Inc., a specialty biologics and vaccines company, today announced that it has acquired assets relating to the vaccine HibTITER from Wyeth LLC, a wholly owned subsidiary of Pfizer Inc, for the U.S. and many other markets, including Japan and Korea. Financial terms of the sale were not disclosed.

View full resource at news-medical.net

Tags: Vaccination, Meningitis, Biotech, Vaccine, Pfizer, Wyeth, News